☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
App
Advertisement
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Autoimmune
Innovent Collaborates with Bolt to Develop Three Oncology Boltbody ISAC Programs
August 27, 2021
Innovent Collaborates with Bolt to Develop Three Oncology Boltbody ISAC Programs
August 27, 2021
Sanofi Signs a Three-Year Collaboration with Stanford Medicine to Accelerate Immunology Research
May 6, 2021
Sanofi Signs a Three-Year Collaboration with Stanford Medicine to Accelerate Immunology Research
May 6, 2021
Sanofi Signs a Three-Year Collaboration with Stanford Medicine to Accelerate Immunology Research
May 6, 2021
AbbVie to License I-Mab's Lemzoparlimab (TJC4) for ~$2B
September 4, 2020
Load more...
Back to Home